Emergency Medical Research Journals

Emergency Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Recchia T et al. - The use of bevacizumab in selected cases of ROP may facilitate disease regression without obvious systemic toxicity. Eyes in which full laser photocoagulation was insufficient has demonstrated promising results. In untreated eyes, the use of bevacizumab may permit a less complicated and more complete definitive treatment. Optimization of dosing, timing, and indications will require additional study.

Related Articles

Retinopathy - screening recommendations
Australian Family Physician, 10/06/09    Relevance Score: 92%

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment
Acta Ophthalmologica, 11/18/09    Relevance Score: 89%

Glyceraldehyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopathy
Investigative Ophthalmology and Visual Science, 11/18/09    Relevance Score: 88%

Prevalence and Severity of Hypertensive Retinopathy in Children
Clinical Pediatrics, 10/22/09    Relevance Score: 88%

Diabetic Retinopathy Screening Update
Clinical Diabetes, 10/19/09    Relevance Score: 88%

Today in Ophthalmology...keeping you current

Positive Influence of Hyaluronate on Cell Vitality of Human Conjunctival Cells after Alkali Injuries
Ophthalmologica, 12/04/09

Measurements of Orbital Volume Change Using Computed Tomography in Isolated Orbital Blowout Fractures
Archives of Facial Plastic Surgery, 12/02/09

Chorioretinectomy for perforating or severe intraocular foreign body injuries
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/01/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address